Gender as a Risk Factor for Adverse Events to Medications Judith C. KandoKimberly A. YonkersJonathan O. Cole Leading Article 03 November 2012 Pages: 1 - 6
Thrombolytic Agents in Development Marc VerstraeteHenri R. LijnenDesiré Collen Review Article 03 November 2012 Pages: 29 - 42
Guidelines for the Use of Zidovudine in Pregnant Women with HIV Infection Marco De SantisGiuseppe NoiaSalvatore Mancuso Practical Therapeutics 03 November 2012 Pages: 43 - 47
A Guide to the Treatment of Lower Respiratory Tract Infections Friedrich Vogel Practical Therapeutics 03 November 2012 Pages: 62 - 72
Meropenem Lynda R. WisemanAntona J. WagstaffHarriet M. Bryson Drug Evaluation 03 November 2012 Pages: 73 - 101
Alteplase Jane C. GillisAntona J. WagstaffKaren L. Goa Drug Evaluation 03 November 2012 Pages: 102 - 136
Sulfasalazine Christopher P. RainsStuart NobleDiana Faulds Drug Evaluation 03 November 2012 Pages: 137 - 156
Erratum to Tianeptine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression M. I. WildeP. Benfield Erratum 03 November 2012 Pages: 156 - 156
Transnasal Butorphanol Jane C. GillisPaul BenfieldKaren L. Goa Drug Evaluation 03 November 2012 Pages: 157 - 175